Oxford Nanopore Technologies plc (LON:ONT)
138.40
+1.40 (1.02%)
Nov 3, 2025, 1:43 PM BST
Oxford Nanopore Technologies Employees
Oxford Nanopore Technologies had 1,382 employees as of December 31, 2024. The number of employees increased by 144 or 11.63% compared to the previous year.
Employees
1,382
Change (1Y)
144
Growth (1Y)
11.63%
Revenue / Employee
154.48K GBP
Profits / Employee
-108.14K GBP
Market Cap
1.32B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1,382 | 144 | 11.63% |
| Dec 31, 2023 | 1,238 | 229 | 22.70% |
| Dec 31, 2022 | 1,009 | 206 | 25.65% |
| Dec 31, 2021 | 803 | 276 | 52.37% |
| Dec 31, 2020 | 527 | 61 | 13.09% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 94,300 |
| GSK plc | 68,629 |
| Haleon | 24,561 |
| Smith & Nephew | 17,349 |
| Spire Healthcare Group | 15,703 |
| ConvaTec Group | 10,489 |
| Hikma Pharmaceuticals | 9,500 |
| Genus | 3,190 |
Oxford Nanopore Technologies News
- 18 days ago - Oxford Nanopore Announces PromethION Plus Flow Cell and Human Genetics Updates at ASHG 2025 - Business Wire
- 25 days ago - Bio-Techne (TECH) Expands Partnership with Oxford Nanopore Technologies - GuruFocus
- 2 months ago - Half Year 2025 Oxford Nanopore Technologies PLC Earnings Presentation Transcript - GuruFocus
- 2 months ago - Oxford Nanopore Technologies plc (ONTTF) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Oxford Nanopore Technologies plc 2025 Q2 - Results - Earnings Call Presentation - Seeking Alpha
- 2 months ago - FTSE Falls as Starmer Resets Government - Investomania
- 2 months ago - UK Stock Market News: Michelmersh Brick, WizzAir, Oxford Nanopore - The Armchair Trader
- 3 months ago - ViruSure launches pioneering first-in-class viral contamination test for biopharmaceuticals using Oxford Nanopore technology - Business Wire